🇺🇸 FDA
Patent

US 9808486

Administration of kynurenine depleting enzymes for tumor therapy

granted A61KA61K35/17A61K38/00

Quick answer

US patent 9808486 (Administration of kynurenine depleting enzymes for tumor therapy) held by The Board of Regents of the University of Texas System expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K35/17, A61K38/00, A61K38/46, A61P